Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

AVNS holding history

Avanos Medical, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVNS overviewAll 13F holders of AVNSFull Q2 2026 holdings

Shares (Q2 2026)
280,729
Value
$6.98M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AVNS by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026280,729$6.98M<0.1%−390,684−58.2%ReducedHolders
Q1 2026671,413$9.41M<0.1%−539,043−44.5%ReducedHolders
Q4 20251,210,456$13.6M<0.1%−88,587−6.8%ReducedHolders
Q3 20251,299,043$15.0M<0.1%+107,121+9.0%AddedHolders
Q2 20251,191,922$14.6M<0.1%+102,947+9.5%AddedHolders
Q1 20251,088,975$15.6M<0.1%+594,348+120.2%AddedHolders
Q4 2024494,627$7.87M<0.1%+148,902+43.1%AddedHolders
Q3 2024345,725$8.31M<0.1%−140,822−28.9%ReducedHolders
Q2 2024486,547$9.69M<0.1%+74,767+18.2%AddedHolders
Q1 2024411,780$8.20M<0.1%+77,663+23.2%AddedHolders
Q4 2023334,117$7.49M<0.1%−43,996−11.6%ReducedHolders
Q3 2023378,113$7.65M<0.1%+8,548+2.3%AddedHolders
Q2 2023369,565$9.45M<0.1%−147,816−28.6%ReducedHolders
Q1 2023517,381$15.4M<0.1%−98,641−16.0%ReducedHolders
Q4 2022616,022$16.7M<0.1%−102,999−14.3%ReducedHolders
Q3 2022719,021$15.7M<0.1%−61,613−7.9%ReducedHolders
Q2 2022780,634$21.3M<0.1%−116,815−13.0%ReducedHolders
Q1 2022897,449$30.1M<0.1%+124,254+16.1%AddedHolders
Q4 2021773,195$26.8M<0.1%+70,960+10.1%AddedHolders
Q3 2021702,235$21.9M<0.1%+187,548+36.4%AddedHolders
Q2 2021514,687$18.7M<0.1%+320,127+164.5%AddedHolders
Q1 2021194,560$8.51M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.